相关实验视频
Updated: Jun 12, 2025

05:07
Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
Published on: June 23, 2019
6.6K
发现和优化Aryl Piperidinone尿酸作为选择性甲基受体2激活剂
Nicholas R Wurtz1, Pravin S Shirude2, Daniel L Cheney1
1Bristol Myers Squibb, Princeton, New Jersey 08543, United States.
ACS medicinal chemistry letters
|September 18, 2024
概括
研究人员发现了强效的阿里尔皮佩里迪氨酸激动剂,向甲基受体2 (FPR2). 这些化合物通过在体内诱导INTERLEUKIN-10 (IL10) 来治疗炎症有望.
科学领域:
- 药用化学 医学化学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲基受体 (FPR),特别是FPR2,是免疫反应的关键调节者.
- 准FPR2为炎症性疾病提供了潜在的治疗策略.
- 之前的研究已经确定了有限的FPR2激动因子,其表现不佳.
研究的目的:
- 发现和优化新型的氨酸衍生物作为强效和选择性的FPR2激动剂.
- 阐明FPR2对FPR1.1的选择性的结构基础.
- 在炎症的临床前模型中评估已识别的激动剂的疗效.
主要方法:
- 高通量选 (HTS) 用于识别最初的结果.
- 结构-活动关系 (SAR) 研究用于优化.
- 分子对接到FPR2和FPR1的冷EM结构,以了解选择性.
- 在大鼠脂聚糖 (LPS) 诱导炎症模型中的体内评估.
主要成果:
- 从一个HTS中标中鉴定出有力的和有选择性的aryl piperidinone urea FPR2激动剂.
- 关于FPR2对FPR1.1的选择性的建议结构基础.
- 化合物显示出有利的ADME配置文件.
- 在LPS诱导的炎症模型中,选择的激动剂诱导了剂量依赖的INTERLEUQIN-10 (IL10).
结论:
- 这种新型的阿里尔皮佩里迪诺尿素支架代表了一类有前途的FPR2激动剂.
- 这些化合物在炎症性疾病中具有治疗干预的潜力.
- 这项研究提供了FPR2向炎症解决方案的概念证明.
更多相关视频
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.6K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.6K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Structure-Activity Relationships and Drug Design
676
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
676

